, transient co-overexpression of CSQ and TRN resulted in a reduced survival rate, an increased cardiac fibrosis, and a decreased basal contractility in catheterized mice, working heart preparations, and isolated myocytes. Echocardiographic and hemodynamic measurements revealed a depressed cardiac performance after isoproterenol application in TG CxT compared with TG CSQ
2ϩ storage protein that interacts with triadin (TRN), the ryanodine receptor (RyR), and junctin (JUN) to form a macromolecular tetrameric Ca 2ϩ signaling complex in the cardiac junctional sarcoplasmic reticulum (SR). Heart-specific overexpression of CSQ in transgenic mice (TG CSQ ) was associated with heart failure, attenuation of SR Ca 2ϩ release, and downregulation of associated junctional SR proteins, e.g., TRN. Hence, we tested whether co-overexpression of CSQ and TRN in mouse hearts (TG CxT and TG CSQ compared with wild-type hearts. As a result of these expressional changes, the SR Ca 2ϩ load was higher in both TG CxT and TG CSQ myocytes. In contrast to the improved cellular Ca 2ϩ , transient co-overexpression of CSQ and TRN resulted in a reduced survival rate, an increased cardiac fibrosis, and a decreased basal contractility in catheterized mice, working heart preparations, and isolated myocytes. Echocardiographic and hemodynamic measurements revealed a depressed cardiac performance after isoproterenol application in TG CxT compared with TG CSQ . Our results suggest that co-overexpression of CSQ and TRN led to a normalization of the SR Ca 2ϩ release compared with TG CSQ mice but a depressed contractile function and survival rate probably due to cardiac fibrosis, a lower SERCA2a expression, and a blunted response to ␤-adrenergic stimulation. Thus the TRN-to-CSQ ratio is a critical modulator of the SR Ca 2ϩ signaling.
contractility; calcium signaling; sarcoplasmic reticulum; overexpression; heart failure IN CARDIAC MYOCYTES, THE RELEASE of Ca 2ϩ from the sarcoplasmic reticulum (SR) is the crucial process for the initiation of contraction. It has been shown that the SR luminal Ca 2ϩ -binding protein calsequestrin (CSQ) plays an important role in SR function by interacting with the SR Ca 2ϩ release channel (36) . CSQ was characterized as a highly acidic protein that binds Ca 2ϩ with high capacity and undergoes major conformational changes after Ca 2ϩ binding (10, 27) . Polymerization occurs at high SR Ca 2ϩ content and increases the Ca 2ϩ -binding capacity of the protein itself (30) . The importance of CSQ in regulating cardiac contractility was demonstrated by use of transgenic models. Cardiac-specific overexpression of CSQ increased SR Ca 2ϩ storage capacity of myocytes but was associated with an attenuation of SR Ca 2ϩ release, leading to a depressed cardiovascular function and premature death (12, 35) . Moreover, these changes in SR Ca 2ϩ handling were associated with downregulation of junctional SR proteins [e.g., triadin (TRN)].
It is commonly believed that CSQ acts not only as a local intra-SR Ca 2ϩ buffer but as a Ca 2ϩ -dependent regulator of ryanodine receptor (RyR) function (9, 19) . SR Ca 2ϩ release is controlled by a tetrameric protein complex that is localized at the junctional SR and consists of the RyR, TRN, junctin (JUN), and CSQ. Functional interactions among TRN, JUN, and CSQ can modulate the responsiveness of the RyR to luminal Ca 2ϩ (9, 36, 37 TRN is an integral membrane protein that is composed of a single membrane spanning domain, a short cytoplasmic NH 2 -terminal segment, and a long, highly positively charged COOH-terminal domain extending into the lumen of the SR (20) . These molecular characteristics provide the structural basis for coordinated interactions between the proteins of the tetrameric complex during excitation-contraction (E-C) coupling. This suggests that the TRN expression level is a critical determinant of SR Ca 2ϩ handling. Indeed, ablation of TRN causes the loss of Ca 2ϩ release units, impaired E-C coupling, and cardiac arrhythmias (4) . Moreover, the protein expression of junctional SR proteins (e.g., CSQ) was lower in TRN knockout mouse hearts, which was surprising since transgenic overexpression of TRN was associated with similar effects (15) . Thus it remains to be elucidated whether the lower expression level of TRN in CSQ-overexpressing mice reflects either a protective mechanism in maintaining cardiac function or rather a negative consequence of CSQ overexpression resulting in subsequent heart failure. This led us to the question whether a normalization of the impaired TRN-to-CSQ protein ratio may improve the depressed SR Ca 2ϩ handling in CSQoverexpressing myocytes and restore cardiac contractility.
Therefore, the primary goal of the present study was the functional characterization of double transgenic mice with heart-directed overexpression of CSQ and TRN. The effects on SR Ca 2ϩ handling and cardiac performance were tested in vivo, in whole hearts, and in isolated myocytes.
METHODS
Experimental animals. Generation of transgenic mouse lineages overexpressing either cardiac canine TRN1 or calsequestrin was performed by use of the cardiac-specific ␣-myosin heavy chain promoter as described previously (12, 21) . Littermate mouse quadruplets derived from cross-breeding of both lineages, resulting in wildtype (WT), triadin-overexpressing (TG TRN ), calsequestrin-overexpressing (TG CSQ ), and double transgenic mice (TG CϫT ), were studied. Screening for transgene-positive mice was done by standard PCR techniques. Cross-breeded mice of the fifth generation or older in the age of 5-6 wk were used for all experiments. Animals were handled and maintained according to approved protocols of the University of Münster Animal Welfare Committee.
Histological, immunofluorescence, and electron microscopy analysis. For histological examination of left ventricles, longitudinal cuts were made along the length of the myocardium and immediately fixed in 4% buffered formalin, dehydrated, and embedded in paraffin. Tissue sections of 5-m thickness were deparaffinized, rehydrated, and stained by the protocol of trichrome Masson-Goldner for estimation of interstitial fibrosis. To determine whether transgenic canine TRN colocalizes with endogenous mouse JUN, we performed indirect immunofluorescence in TG TRN myocytes. A suspension of cardiac myocytes (ϳ100 l) was placed into polylysine-covered chamber slides (Thermo Scientific). The cells were fixed in precooled methanol for 5 min and then washed with PBS (Ϯ1% BSA) for 15 min. PBS was used in all following dilutions and washing steps. To block unspecific binding sites, incubation with the Fab fragment of goat anti-mouse IgG (100 g/ml; Dianova) was performed. Myocytes were then immunolabeled with mouse monoclonal antibody 8G5 (15) raised against canine TRN (1:300) and rabbit polyclonal antibody JCN4 raised against murine JUN (1:300) for 1 h. Primary antibodies were visualized with goat anti-mouse Alexa Fluor 594 (Invitrogen; 1:300) and goat anti-rabbit Alexa Fluor 488 (1:300), respectively, using confocal microscope LSM 710 Meta (Zeiss, Germany). Finally, the red (for TRN) and green (for JUN) fluorescence components were recorded and merged for analysis. Electron microscopy was performed on small pieces of ventricular heart tissue as described previously (15) .
SDS-PAGE and Western blotting. To determine the protein expression of SR proteins, hearts were excised and immediately homogenized for 90 s at 4°C in 1 ml of medium containing 10 mM histidine and 0.25 M sucrose (pH 7.4). Protein concentrations were determined in heart homogenates (26) . Thereafter, samples were solubilized in 5% SDS buffer (for composition, see Ref. 15) . Fifty micrograms of homogenate protein were separated on 8% SDS-PAGE (32) . To determine protein expression of the RyR, 200 g of homogenate protein were subjected to 5% PAGE. Separated proteins were transferred to nitrocellulose membranes and incubated with different antibodies. The primary antibodies recognizing the RyR, CSQ, TRN, JUN, L-type Ca 2ϩ channel (Cav1.2), sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a (SERCA2a), or phospholamban were used as described previously (5, 7, 17) . The amounts of bound primary antibodies were detected by 125 I-labeled protein A (Amersham Biosciences). Echocardiography. Echocardiographic measurements were performed on sedated mice (diazepam: 17.5 mg/kg body wt ip) as described previously (18) . Cardiac dimensions, left ventricular wall thickness, and cardiac function were assessed by M-Mode, twodimensional echocardiography, and Doppler measurements (18) . Echocardiographic parameters were determined under basal and acute isoproterenol (ISO)-stimulated conditions (ip bolus injection: 1 mg/kg body wt).
Left ventricular catheterization. Left ventricular catheterization was performed in closed-chest mice (14) . Briefly, the left jugular vein was cannulated with a custom-fashioned polyethylene tube connected to a microinfusion pump for drug administration. The polyethylene catheter (Micro-Med) was inserted into the aorta via the right carotid artery and advanced into the left ventricle under continuous monitoring of the pressure waveform. Analog pressure signals were obtained by using the pressure transducer TXD-310 (Micro-Med), recorded, and digitized at a sampling rate of 1,000 Hz and a sampling period of 1 min with the PowerLab system (ADInstruments), as described previously (24) . Heart rate, left ventricular pressure, and the first derivatives of left intraventricular pressure (ϮdP/dt) were monitored continuously, recorded, and analyzed after a 10-min period of stabilization. Increasing doses of dobutamine were injected into the left jugular vein, and the effects on above parameters were determined.
Work-performing heart preparations. Work-performing heart preparations were utilized as described previously (15) using a perfusion system for isolated hearts (Hugo Sachs Elektronik). Mice were anaesthetized intraperitoneally with urethane (2.0 g/kg body wt) and treated with 1.5 U of heparin. Hearts were removed from the opened chest and perfused retrogradely with oxygenized Krebs-Henseleit buffer (37°C) containing 118 mM NaCl, 25 mM NaHCO 3, 0.5 mM Na-EDTA, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2.5 mM CaCl2, and 11 mM glucose. During the short period of retrograde perfusion in the Langendorff modus, the pulmonary vein was cannulated. The perfusion of the heart was then changed to an anterograde mode. Heart rate and first derivatives of left intraventricular pressure (ϮdP/dt) were recorded at an afterload of 50 mmHg and a perfusion rate of 5 ml/min.
Isolation of ventricular myocytes. Ventricular myocytes were isolated enzymatically using a slight modification of a protocol published before (15) . First, the mice were pretreated with heparin (1.5 U) and asphyxiated with carbon dioxide. After bilateral thoracotomy, the hearts were quickly excised and cannulated through the aorta fixed in the Langendorff apparatus. Isolated hearts were perfused for 5 min at 2.5 ml/min with Ca 2ϩ -free perfusion buffer (37°C) containing 113 mM NaCl, 4.7 mM KCl, 0.6 mM KH2PO4, 0.6 mM NaH2PO4, 12 mM NaHCO3, 10 mM KHCO3, 30 mM taurin, 10 mM HEPES, 10 mM 2,3-butanedione monoxime, and 11 mM glucose (pH 7.45), followed by a perfusion for 5 min with enzyme solution [perfusion buffer supplemented with 67.3 g/ml liberase DH (Roche Molecular Biochemicals), 0.15 mg/ml trypsin, and 12.5 M CaCl2]. After enzymatic digestion, the ventricles were separated, gently mechanically agitated, and filtered through a nylon mesh. A gradual elevation of CaCl2 to a final concentration of 1 mM was performed in five steps with 3-min intervals. Finally, the myocyte suspension was centrifuged at 42 g for 1 min, and the pellet was resuspended in perfusion buffer supplemented with 1 mM CaCl2. The myocytes were stored at room temperature (RT), and all experiments were performed within the next 6 h. 3 H]ryanodine. Nonspecific binding was determined in the same buffer in the presence of 10 M cold ryanodine. Samples were filtered (Millipore) and rinsed repetitively with ice-cold saline, and the remaining radioactivity on the filters was quantified in a liquid scintillation counter.
Statistics. Data are reported as means Ϯ SE. All of our data were distributed normally, which was confirmed by Shapiro-Wilk normality test. Statistical differences between groups were calculated by ANOVA followed by Bonferroni's t-test. P Ͻ 0.05 was considered significant.
RESULTS

Heart-directed overexpression of TRN and CSQ in mice.
The overexpression of dog TRN and/or CSQ in myocardium was achieved by use of the ␣-myosin heavy chain promoter (8) . Successful TRN and/or CSQ overexpression was confirmed by PCR (Fig. 1A) and quantified in transgenic mouse hearts on protein level (Fig. 1B) . This analysis revealed a comparable overexpression of CSQ in TG CSQ and TG CxT mice (Table 1 ) and of TRN in TG TRN and TG CxT mice (Table 1) . Of note, the protein level of TRN was reduced by 52% in TG CSQ compared with WT mice (Table 1) . After all, the TRN-to-CSQ ratio was normalized in double transgenic TG CxT mice. Immunofluorescence analysis of isolated myocytes, using a mouse monoclonal antibody that recognizes exogenous canine but no endogenous mouse TRN, exhibited expression of the transgenic protein along the sarcomeric structure in TG TRN myocytes (Fig. 1C) . This suggests the expression of a functional relevant dog TRN in transgenic mouse hearts. Because of lack of a specific antibody directed against dog CSQ, it was not possible to determine the location of this transgenic protein.
Moreover, these measurements revealed the colocalization of canine TRN and endogenous mouse JUN using confocal microscopy (Fig. 1C) , suggesting normal trafficking of overexpressed TRN. Electron microscopy analysis revealed that the content of the junctional SR appears denser in TG TRN (Fig. 1D , top right) compared with WT hearts (Fig. 1D, top left) . This suggests that TRN overexpression holds CSQ in a condensed configuration. Transgenic overexpression of CSQ is followed by a massive swelling of SR vesicles (Fig. 1D, middle left) , which are filled with a network of elongated CSQ polymers (6) . Interestingly, co-overexpression results in a coexistence of small (Fig. 1D, bottom left) and wide SR vesicles (Fig. 1D,  middle right) . Overall, it appears that the width of junctional SR vesicles is reduced in TG CxT (Fig. 1D, bottom Figure 2A shows the survival curves for all mouse lineages tested. Interestingly, we observed that TG CxT mice had no benefit from the higher TRN expression compared with TG CSQ mice. The double transgenic mice showed even an additional reduction of the survival rate (P Ͻ 0.05). At the age of 8 wk, Ͼ80% of TG CxT mice were dead. In contrast, the same mortality rate was recorded after 24 wk of age in TG CSQ mice ( Fig. 2A) . This was the first indication that the co-overexpression of both CSQ and TRN has detrimental effects on the viability of transgenic mice. Therefore, we studied the structural and functional mecha- Fig. 2 . Survival of all genotypes was registered over a period of 12 mo (A). Numbers in parentheses indicate the numbers of animals at the beginning of observations and residual animals after 12 mo. Log-Rank test revealed significant differences between all groups except WT vs. TRN, where we did not register any alterations in survival probability. Cardiac hypertrophy was detected in both TG CSQ and TG CxT mice by measurement of heart weight (HW)-to-body weight (BW) ratios (B). Ventricular fibrosis was revealed by trichrome Masson-Goldner stainings (C). Numbers in parentheses indicate number of animals and hearts used for analysis.
ϩ P Ͻ 0.05 vs. WT; *P Ͻ 0.05 vs. TG TRN .
nisms of this phenomenon. First, we determined the heart weight-to-body weight ratio. Although we found an increase in this ratio in TG CxT compared with TG TRN and WT, there was no further deterioration compared with TG CSQ mice (Fig. 2B) , suggesting a similar degree of myocellular hypertrophy. Histological analysis of ventricular sections using a staining protocol of trichrome Masson-Goldner detected a pronounced interstitial fibrosis in TG CxT hearts (Fig. 2C ). This effect may contribute, at least in part, to the lower survival rate in double transgenic mice. In the next step, we then studied whether the decreased viability is reflected by an impaired contractile function at the whole heart or single cell level.
Reduced fractional shortening in echocardiography after ISO administration in TG
CxT mice. The in vivo ventricular function was investigated by transthoracic echocardiography and Doppler measurements ( Table 2 ). There were no alterations in cardiac parameters between all experimental groups under basal conditions. However, ␤-adrenergic stimulation by ISO revealed an increased left atrial diameter in TG CxT compared with TG CSQ mice. This dilatation might contribute to an impaired cardiac function. Alternatively, this increase reflects a high experimental variability and may have no functional consequences. The fractional shortening (FS), the mean aortic pressure gradient, and the velocity of circumferential fiber shortening were reduced in TG CxT compared with TG TRN and WT mice. FS and velocity of circumferential fiber shortening were also comparably diminished in TG CSQ mice. The acute administration of ISO led to an increase in FS in WT and TG TRN mice (by 38 and 42%, respectively) compared with basal conditions, whereas the ISO effect was lacking in TG CSQ mice compared with basal conditions. In addition, ISO stimulation was associated even with a decrease in FS in TG CxT compared with basal conditions (by 45%). This is in agreement with a 52% higher left ventricular end-systolic diameter under ISO-stimulated conditions in TG CxT mice. These results indicate an impaired ␤-adrenergic response of in vivo cardiac contractility in both TG CSQ and TG CxT mice.
Decreased basal and dobutamine-stimulated contractility in catheterized TG
CxT mice. To characterize in depth the deterioration of the heart function in TG CxT mice, we also studied cardiac contractility by left ventricular catheterization. The rate of ventricular contraction (ϩdP/dt) was impaired in all transgenic groups compared with WT mice (Fig. 3A) (Fig. 3B) . However, there was no difference of this parameter between TG CSQ and TG CxT mice. Cardiac performance was also examined under ␤-adrenergic stimulation by dobutamine administration. In the present study, we missed an increase of contractility in TG CxT mice compared with WT and TG TRN mice for almost all dobutamine concentrations (Fig.  3C ). The rate of pressure development was decreased by 66% under the maximum concentration of dobutamine in TG CxT compared with TG CSQ mice. The rate of pressure decline and the heart rate (data not shown) exhibited a comparable behavior for all groups tested. Thus these data confirmed the reduced contractile responsiveness to ␤-adrenergic stimulation in TG CxT mice observed by echocardiography.
Impaired contractile parameters in work-performing heart preparations of TG
CxT mice. To test whether the reduction of cardiac performance in TG CxT mice under basal and ISOstimulated conditions is also observed ex vivo, we used isolated work-performing heart preparations eliminating a potential neuronal and/or humoral contribution to the contractile effects. Under basal loading conditions (i.e., 50 mmHg after- load), WT and TG TRN mice exhibited similar spontaneous heart rates, whereas TG CSQ and TG CxT mice were characterized by reduced heart rates (Fig. 4A ). This reduction is in contrast to echocardiographic and invasive hemodynamic measurements, where no alterations in heart rate were observed among all groups, suggesting the activation of the sympathetic nervous system in the intact organism. The rate of contraction (ϩdP/dt) was decreased by 57% in isolated TG CxT compared with WT hearts (Fig. 4B) . Moreover, the rate of relaxation (ϪdP/dt) was reduced by 55% in TG CxT and by 34% in TG TRN compared with WT hearts (Fig. 4C) (Fig. 5B) . In contrast, the time of 90% relaxation was not different between all experimental groups (Fig. 5C ). Although the application of ISO was associated with an increase in cell shortening and a reduction in time of relaxation (TOR 90% ) compared with basal values (Fig. 5, B and C) , we found no differences in these parameters between all experimental groups. There was only a tendency for a prolonged TOR 90% both in TG CSQ and TG CxT . Simultaneous measurements of Ca 2ϩ transients (Fig. 5D ) revealed a concomitant decrease of the twitch [Ca] i peak amplitude in TG CSQ myocytes (by 25% vs. WT). However, this decrease was normalized in TG CxT myocytes (Fig. 5E) , suggesting an uncoupling of the Ca 2ϩ -induced contraction process in double transgenic hearts. Analysis of the [Ca] i 50% decay exhibited a similar prolongation in TG CSQ and TG CxT (by 131 and 139%, respectively) compared with WT myocytes (Fig. 5F) .
Impaired transients were also detected in TG CxT myocytes (by 727% vs. WT). However, there was no difference between myocytes from TG CSQ and TG CxT mice. These data led to the question whether an altered expression of SR proteins causes the different intracellular Ca 2ϩ handling observed in TG CxT myocytes (Fig. 6A and 
TG
CxT compared with WT heart homogenates ( Table 1) . SERCA2a levels were also depressed against TRN-and CSQoverexpressing mouse hearts. The protein expression of phospholamban was similar in all groups (Table 1 ). These data suggest that the replacement of cardiac myocytes by fibrotic tissue may contribute, at least in part, to a reduction in the expression of main regulatory SR proteins in TG CxT despite a comparable increase in heart weight both in TG CSQ and TG CxT .
DISCUSSION
Structural and functional defects of proteins forming the junctional SR Ca 2ϩ release complex represent an important feature of cardiac hypertrophy, heart failure, or ventricular arrhythmias (11, 23, 33, 34) . The exact mechanisms, underlying the mode of interaction between CSQ and associated proteins within this complex, have not been understood in total. Studies with heart-specific overexpression of CSQ reported the presence of hypertrophy, impaired cellular Ca 2ϩ handling, depressed contractility, and downregulation of TRN, JUN, and RyR protein expression (12) . Interestingly, ablation of CSQ in mice was associated with normal basal cardiac function but led to a propensity for stress-induced ventricular arrhythmias and downregulation of TRN and JUN as well (19) . This suggests that an altered stoichiometry between CSQ and its interacting partner proteins may result in an impaired SR Ca 2ϩ release process. Thus we tested whether an additional overexpression of TRN can restore depressed cardiac function in TG CSQ mice. On the basis of individual TRN-to-CSQ ratios and functional data, a model is provided from which it can be deduced, at least in part, changes in Ca 2ϩ handling and contractility loss (Fig. 7) .
The importance of an intermolecular regulation inside the SR Ca 2ϩ release complex was underlined by several studies (4, 12, 15, 16, 19) showing that overexpression or deletion of junctional SR proteins was associated with a reduction in their partner proteins. However, it was not clear from these studies whether this altered expression has protective or detrimental effects on the SR Ca 2ϩ release process. In the present study, an increase in the TRN-to-CSQ ratio had no functional effects on [Ca] i peak amplitude or cellular contractility in TG TRN mice. Normally, TRN is required to physically link the RyR with CSQ (9) . Thus the excess of TRN in the junctional SR membrane seems to hold CSQ in a condensed configuration appearing as a dense structure in electron microscopy analysis of TG TRN hearts (6) . Moreover, the reduced expression of JUN, which can also function as a CSQ-anchoring protein at the junctional SR, may compensate for the TRN overexpression. This helps to maintain a normal SR Ca 2ϩ content and Ca 2ϩ release.
In TG CSQ hearts, the decrease of the TRN-to-CSQ ratio was paralleled by a lower [Ca] (Fig. 7) . It needs to be elucidated which process(es) is(are) responsible for the initial reduction of TRN expression in TG CSQ hearts. On the other hand, the prolonged decay of [Ca] i may be caused by an increased expression of phospholamban.
Regarding to our mechanistic model, an additional expression of TRN in TG CSQ hearts may cause a normalized ratio of both proteins, although the exact stoichiometry is not known, and therefore a better coupling between CSQ and the RyR (Fig.  7) . As a consequence more SR-luminal Ca 2ϩ , which is buffered by TRN-bound CSQ in the vicinity of RyR release sites, is now available for the release from the SR resulting in the normalization of the [Ca] i peak amplitude in TG CxT myocytes, i.e., the reduced expression of TRN in TG CSQ has rather detrimental effects on the SR Ca 2ϩ release process. More evidence for this suggestion is coming from electron microscopy studies by us and others (6) transients, TG CxT mice were characterized by further deterioration in survival and myocardial contractility at basal conditions and upon ISO administration compared with TG CSQ mice. At baseline, the depressed contractile function was accompanied by a plethora of structural (e.g., extensive fibrosis) and biochemical alterations (e.g., downregulation of SERCA2a). A similar discrepancy between cellular Ca 2ϩ regulation and contractile phenotype was observed in several studies. Myocytes from aortic-banded rats displayed increased systolic [Ca] i but a depressed myocyte shortening, indicating an impaired responsiveness to cytosolic Ca 2ϩ (13) . Skinned fibers from these rats exhibited normal Ca 2ϩ sensitivity of the myofilaments, although the maximum Ca 2ϩ -activated force was depressed. In addition, an increase in systolic [Ca] i and a concomitant depression of the contractile function were measured in papillary muscles of rats suffering on heart failure due to infarction (25) . In this model, authors assume that hyperphosphorylation of myofilament proteins could contribute to a lack of contractile increase despite an elevation of systolic [Ca] i . This was attributed to an increase in PKC␣ activity (2) , which was also observed in transgenic mice with heart-directed overexpression of the ␣ 1 subunit of the L-type Ca 2ϩ channel (28, 29 -dependent signaling cascades. Moreover, these authors reported the development of cardiac hypertrophy in combination with a striking loss of the ISO effects on myocardial contraction, as observed in the present study.
The blunted contractile response to ISO represents a common feature of all heart failure models. In the present study, the application of ISO failed to increase several contractile parameters in echocardiographic and hemodynamic measurements in TG CxT mice. Cardiac catheterization exhibited even a reduced contractility after maximum doses of ISO in TG CxT compared with TG CSQ . We suggest that the massive increase in cardiac fibrosis may contribute to the loss of ISO effects on cardiac performance (22) because isolated myocytes exhibited comparable ISO effects on mechanical shortening. However, it is conceivable that an upregulation of ␤ARK1 (14), diminished phospholamban phosphorylation (14) , and/or SERCA2a downregulation, as found in the present study, may be involved in the loss of inotropic response to ISO administration in TG CxT hearts. Moreover, we suggest that sympathetic stimulation at basal conditions both in TG CSQ and TG CxT mice is so high that the intracellular Ca 2ϩ signaling cannot proper respond to ␤-agonists. This is supported by the observation that heart rates are reduced in isolated working heart preparations but unchanged in echocardiographic in vivo experiments.
In summary, co-overexpression of CSQ and TRN led to a normalization of the [Ca] 
